Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peer Christiansen"'
Publikováno v:
Clinical Epidemiology
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
AIM OF DATABASE: Danish Breast Cancer Cooperative Group (DBCG), with an associated database, was introduced as a nationwide multidisciplinary group in 1977 with the ultimate aim to improve the prognosis in breast cancer. Since then, the database has
Publikováno v:
Bodilsen, A, Offersen, B V, Christiansen, P & Overgaard, J 2016, ' Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009 ', Acta Oncologica, pp. 1-6 . https://doi.org/10.3109/0284186X.2016.1167955
BACKGROUND: The continuous improvements in diagnosing and treatment of breast cancer are reflected in the ever changing pattern of recurrence. The aim of the study was to investigating recurrence pattern and prognostic factors of recurrence in a popu
Autor:
Jens Overgaard, Peer Christiansen, Henning T. Mouridsen, Bent Ejlertsen, Niels Kroman, Ann Søgaard Knoop, Birgitte Vrou Offersen, Maj-Britt Jensen
Publikováno v:
Ejlertsen, B, Offersen, B V, Overgaard, J, Christiansen, P, Jensen, M-B, Kroman, N, Knoop, A S & Mouridsen, H 2018, ' Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration ', Acta Oncologica, vol. 57, no. 1, pp. 3-12 . https://doi.org/10.1080/0284186X.2017.1408962
BACKGROUND:Over the past 40 years the Danish Breast Cancer Cooperative Group (DBCG) has made significant contributions to improve outcome and to make treatment of patients with early breast cancer more tolerable through nationwide and international t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7d730a12aeb410ae614cdd12ea42e98
https://pure.au.dk/portal/da/publications/forty-years-of-landmark-trials-undertaken-by-the-danish-breast-cancer-cooperative-group-dbcg-nationwide-or-in-international-collaboration(4aa444ed-ea98-4786-84e7-e4fe620f675e).html
https://pure.au.dk/portal/da/publications/forty-years-of-landmark-trials-undertaken-by-the-danish-breast-cancer-cooperative-group-dbcg-nationwide-or-in-international-collaboration(4aa444ed-ea98-4786-84e7-e4fe620f675e).html
Autor:
Peer Christiansen, Anne Vibeke Lænkholm, Maj-Britt Jensen, Bent Ejlertsen, Henning T. Mouridsen, Birgitte Vrou Offersen, Niels Kroman
Publikováno v:
Jensen, M-B, Laenkholm, A-V, Offersen, B V, Christiansen, P, Kroman, N, Mouridsen, H T & Ejlertsen, B 2018, ' The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016 ', Acta Oncologica, vol. 57, no. 1, pp. 13-18 . https://doi.org/10.1080/0284186X.2017.1404638
BACKGROUND:Since 40 years, Danish Breast Cancer Cooperative Group (DBCG) has provided comprehensive guidelines for diagnosis and treatment of breast cancer. This population-based analysis aimed to describe the plurality of modifications introduced ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4495310fe193d81c6b2686b947c3a2
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
Autor:
Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit, Bent Ejlertsen, Timothy L. Lash, Henrik Toft Sørensen, Thomas P. Ahern, Per Damkier, Rebecca A. Silliman
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805, pp. e021805 . https://doi.org/10.1136/bmjopen-2018-021805
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christiansen, P M, Damkier, P, Ejlertsen, B, Hamilton-Dutoit, S, Kjærsgaard, A, Silliman, R A, Sørensen, H T & Lash, T L 2018, ' Cohort Profile : The Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark ', BMJ Open, vol. 8, no. 7, e021805 . https://doi.org/10.1136/bmjopen-2018-021805
BMJ Open
PurposeThe Predictors of Breast Cancer Recurrence (ProBe CaRe) study was established to evaluate modification of tamoxifen (TAM) effectiveness in premenopausal women through reduced activity of TAM-metabolising enzymes. It comprehensively evaluates t